Blood Typing and Agglutination Lab Guide
Blood Typing and Agglutination Lab Guide
Cross-matching in transfusion medicine tests compatibility between donor and recipient's blood. It ensures recipient safety by mixing donor red cells with recipient serum to check for agglutination, indicating potential immune reaction. This procedure helps prevent transfusion reactions and is crucial when antigens other than ABO and Rh need to be considered .
Agglutination signifies a reaction between antibodies and foreign antigens on red blood cells. In blood typing, agglutination indicates the presence of specific antigens, helping determine blood type. During a transfusion, agglutination of donor cells by recipient antibodies can block vessels, leading to severe transfusion reactions, making agglutination a critical factor in blood compatibility assessments .
To identify an individual's blood type and Rh factor, a finger is pricked, and drops of blood are placed on a slide with added anti-A, anti-B, and anti-D serums. Observations of agglutination indicate the presence of corresponding antigens: agglutination with anti-A serum indicates type A blood, anti-B for type B, and anti-D indicates Rh positive status. No agglutination signifies absence of the relevant antigen .
The main types of antigens present on red blood cells that determine an individual's blood group are the A and B glycolipid antigens in the ABO blood group system and the Rh antigen, particularly the D antigen, in the Rh blood group system .
Environmental exposure influences antibody development in the ABO system by introducing antigens similar to blood group antigens through bacteria, viruses, and pollen. These antigens stimulate immune response, leading to the production of antibodies against non-self ABO antigens, a process absent at birth but beginning around 3-4 months of age .
It is essential to determine both ABO blood type and Rh factor before a blood transfusion to ensure compatibility between donor and recipient, preventing immune reactions. If blood with incompatible ABO antigens is transfused, it can lead to agglutination, which blocks blood vessels and can be fatal . Additionally, if an Rh-negative person receives Rh-positive blood, it can lead to sensitization and serious reactions in future transfusions .
It is important that the serum dropper does not touch the blood drop to avoid contamination and ensure accurate results. Contact can contaminate the serum with blood, potentially altering its composition or causing false agglutination due to non-specific reactions. This could mislead the determination of blood type, leading to errors in typing and transfusion compatibility .
If a non-Rh-negative individual erroneously receives Rh-positive blood, it can lead to sensitization where the recipient's immune system is stimulated to produce antibodies against Rh antigen. This can cause hemolytic reactions, destroy transfused red cells, and complicate future transfusions or pregnancies involving Rh-positive blood .
Antibodies in blood plasma are responsible for blood transfusion reactions by binding to non-self antigens on transfused red blood cells, causing agglutination. In newborns, these antibodies are initially absent but start appearing by 3 to 4 months due to environmental exposure to antigens similar to ABO blood group antigens in bacteria, viruses, and pollen .
Unlike the ABO system, there are no naturally occurring antibodies against the Rh (D) antigen because it is only present on red blood cells and not in body fluids or other tissues, limiting natural exposure. Therefore, Rh antibodies develop only after exposure through transfusion or pregnancy .